South Danish Obesity Initiative, Screening for Unrecognized Obesity Related Disease

Launched by CLAUS BOGH JUHL · Dec 15, 2021

Keywords

ClinConnect Summary

The South Danish Obesity Initiative is a clinical trial that aims to better understand obesity and related health issues. The study is looking at adults aged 18 to 60 who have a body mass index (BMI) of over 30, which is considered obese. It also includes two control groups: one with a BMI between 18.5 and 25, and another with a BMI between 25 and 30. The goal is to screen participants for undetected health problems linked to obesity, such as high blood pressure, diabetes, and sleep apnea, and to assess their quality of life at the beginning of the study, then again after one year and five years.

Participants who are found to have obesity-related health issues will have the opportunity to join a personalized lifestyle program lasting 12 months, which aims to improve their health and self-image. Throughout the study, researchers will collect important health data and physical measurements, and a biobank will be set up for future research. This trial is currently recruiting participants and does not exclude anyone based on other health conditions, making it a valuable opportunity for those who meet the eligibility criteria.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • BMI \>30 (Obese cohort), BMI 20-25 (control group I), BMI 25-30 (control group II)
• • Age 18-60 years
• Exclusion Criteria:
• • None